Peregrine Pharma New (PPHM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PPHM | PLX | GLSI | ||
| Company | Peregrine Pharma New | Protalix Biotherapeutics | Greenwich Lifesciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 4.24 | 2.35 | 13.18 | ||
| High | 4.25 | 2.39 | 13.50 | ||
| Low | 4.18 | 2.33 | 12.51 | ||
| Latest | 4.22 | 2.37 | 12.98 | ||
| Change | +0.03 | unch | -0.21 | ||
| % Change | +0.72% | unch | -1.59% | ||
| Volume | 93,000 | 212,100 | 113,800 | ||
| 20-Day Average Volume | 254,905 | 623,035 | 193,290 | ||
| Previous Close | 4.19 | 2.37 | 13.19 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 4.24 | 2.35 | 18.50 | ||
| 20-Day Raw Stochastic | 27.59% | 58.49% | 3.89% | ||
| 20-Day Relative Strength | 48.73 | 57.22 | 32.31 | ||
| Weighted Alpha | +32.90 | +49.14 | -41.06 | ||
| Today's Opinion | N/A | 56% Buy | 72% Sell | ||
| Previous Opinion | N/A | 56% Buy | 72% Sell | ||
| Last Month's Opinion | N/A | 8% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.76% since 12/29/17 | -0.42% since 07/17/26 | -20.47% since 07/17/26 | ||
| Low | 3.88 on 01/02/18 | 2.31 on 07/22/26 | 12.51 on 07/24/26 | ||
| High | 4.25 on 01/05/18 | 2.45 on 07/20/26 | 17.20 on 07/20/26 | ||
| 1-Month | |||||
| %Chg | -19.77% since 12/05/17 | +5.80% since 06/24/26 | -39.70% since 06/24/26 | ||
| Low | 3.74 on 12/21/17 | 2.19 on 06/25/26 | 12.51 on 07/24/26 | ||
| High | 5.48 on 12/11/17 | 2.48 on 07/13/26 | 24.60 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | +23.39% since 10/05/17 | +8.72% since 04/24/26 | -46.39% since 04/24/26 | ||
| Low | 3.28 on 10/09/17 | 1.88 on 05/19/26 | 12.51 on 07/24/26 | ||
| High | 5.48 on 12/11/17 | 2.48 on 07/13/26 | 29.93 on 06/01/26 | ||
| 6-Month | |||||
| %Chg | -4.31% since 07/05/17 | +13.94% since 01/23/26 | -49.04% since 01/23/26 | ||
| Low | 2.85 on 09/08/17 | 1.88 on 05/19/26 | 12.51 on 07/24/26 | ||
| High | 5.78 on 07/14/17 | 3.19 on 02/23/26 | 34.10 on 01/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 190,786 | 190,956 | 190,520 | ||
| Shares Outstanding, K | 45,210 | 80,572 | 14,678 | ||
| Annual Sales | 57,630,000 | 52,740,000 | 0 | ||
| Annual Net Income | -28,160,000 | -6,600,000 | -19,360,000 | ||
| Last Quarter Sales | 12,780,000 | 33,750,000 | 0 | ||
| Last Quarter Net Income | -12,620,000 | 18,320,000 | -5,660,000 | ||
| 60-Month Beta | 2.74 | 0.00 | 1.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 09/11/17 | 0.22 on 05/13/26 | -0.39 on 06/03/26 | ||
| Earnings Date | 03/12/18 | 08/13/26 | 08/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.17 | 0.00 | ||